EA201990929A1 - In vitro и клеточные анализы измерения активности ботулинических нейротоксинов - Google Patents

In vitro и клеточные анализы измерения активности ботулинических нейротоксинов

Info

Publication number
EA201990929A1
EA201990929A1 EA201990929A EA201990929A EA201990929A1 EA 201990929 A1 EA201990929 A1 EA 201990929A1 EA 201990929 A EA201990929 A EA 201990929A EA 201990929 A EA201990929 A EA 201990929A EA 201990929 A1 EA201990929 A1 EA 201990929A1
Authority
EA
Eurasian Patent Office
Prior art keywords
activity
neurotoxin
neurotoxins
polypeptides
disclosed
Prior art date
Application number
EA201990929A
Other languages
English (en)
Other versions
EA039761B1 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EA201990929A1 publication Critical patent/EA201990929A1/ru
Publication of EA039761B1 publication Critical patent/EA039761B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

В настоящем документе раскрыты средства обнаружения и определения характеристик нейротоксинов, таких как ботулинический нейротоксин (BoNT) или столбнячный нейротоксин. В настоящем документе предложены способы определения силы и активности нейротоксинов in vitro и in vivo. Также раскрыты полипептиды, содержащие N- и C-концевые фрагменты репортерного белка, разделенные линкером, содержащим участок расщепления нейротоксином. Расщепление линкера нейротоксином снижает активность репортерного белка, тем самым указывая на активность нейротоксина. Также раскрыты композиции и наборы, содержащие раскрытые полипептиды, нуклеиновые кислоты, содержащие нуклеотидные последовательности, кодирующие такие полипептиды, и клетки, экспрессирующие такие полипептиды.
EA201990929A 2016-10-20 2017-10-19 In vitro и клеточные анализы измерения активности ботулинических нейротоксинов EA039761B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662410558P 2016-10-20 2016-10-20
PCT/US2017/057411 WO2018075783A2 (en) 2016-10-20 2017-10-19 In vitro and cell based assays for measuring the activity of botulinum neurotoxins

Publications (2)

Publication Number Publication Date
EA201990929A1 true EA201990929A1 (ru) 2019-10-31
EA039761B1 EA039761B1 (ru) 2022-03-10

Family

ID=60413254

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990929A EA039761B1 (ru) 2016-10-20 2017-10-19 In vitro и клеточные анализы измерения активности ботулинических нейротоксинов

Country Status (19)

Country Link
US (2) US11306347B2 (ru)
EP (1) EP3529616B1 (ru)
JP (2) JP7227901B2 (ru)
KR (1) KR102556363B1 (ru)
CN (1) CN110088624B (ru)
AU (1) AU2017345560A1 (ru)
BR (1) BR112019007831A2 (ru)
CA (1) CA3040507A1 (ru)
DK (1) DK3529616T3 (ru)
EA (1) EA039761B1 (ru)
ES (1) ES2963830T3 (ru)
FI (1) FI3529616T3 (ru)
HU (1) HUE064332T2 (ru)
MX (2) MX2019004431A (ru)
PL (1) PL3529616T3 (ru)
PT (1) PT3529616T (ru)
SA (1) SA519401607B1 (ru)
SG (1) SG11201903523YA (ru)
WO (1) WO2018075783A2 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2655614B1 (en) 2010-12-22 2017-03-15 President and Fellows of Harvard College Continuous directed evolution
US10920208B2 (en) 2014-10-22 2021-02-16 President And Fellows Of Harvard College Evolution of proteases
WO2016168631A1 (en) 2015-04-17 2016-10-20 President And Fellows Of Harvard College Vector-based mutagenesis system
US10392674B2 (en) 2015-07-22 2019-08-27 President And Fellows Of Harvard College Evolution of site-specific recombinases
US11524983B2 (en) 2015-07-23 2022-12-13 President And Fellows Of Harvard College Evolution of Bt toxins
WO2017019895A1 (en) 2015-07-30 2017-02-02 President And Fellows Of Harvard College Evolution of talens
WO2017201105A1 (en) * 2016-05-16 2017-11-23 President And Fellows Of Harvard College Method for purification and activation of botulinum neurotoxin
SG11201903523YA (en) 2016-10-20 2019-05-30 Harvard College In vitro and cell based assays for measuring the activity of botulinum neurotoxins
WO2019010164A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College EVOLUTION OF ARNT SYNTHÉTASES
US11624130B2 (en) 2017-09-18 2023-04-11 President And Fellows Of Harvard College Continuous evolution for stabilized proteins
WO2019241649A1 (en) 2018-06-14 2019-12-19 President And Fellows Of Harvard College Evolution of cytidine deaminases
WO2021011579A1 (en) * 2019-07-15 2021-01-21 President And Fellows Of Harvard College Evolved botulinum neurotoxins and uses thereof
WO2021195479A1 (en) * 2020-03-26 2021-09-30 Cellex, Inc. Protease assays and their applications
CN114540419A (zh) * 2022-03-04 2022-05-27 中国人民解放军军事科学院军事医学研究院 一种分析包膜病毒膜融合效率的三功能报告系统
GB202213479D0 (en) 2022-09-14 2022-10-26 Ipsen Biopharm Ltd Cell-free clostridial neurotoxin assays

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
US4950588A (en) 1985-07-10 1990-08-21 Molecular Diagnostics, Inc. Prolonged enhanced chemiluminescence
DE3537877A1 (de) 1985-10-24 1987-04-30 Geiger Reinhard Luciferin-derivate und immunoassays unter einsatz derartiger luciferin-derivate
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US5374534A (en) 1990-07-19 1994-12-20 Charm Sciences, Inc. Method of preparing D-luciferin derivatives
DE4210759A1 (de) 1992-04-01 1993-10-07 Boehringer Mannheim Gmbh Substituierte Thiazolin-Dioxetan-Substrate, Verfahren zur Herstellung und Verwendung
ES2138740T3 (es) 1994-05-31 2000-01-16 Allergan Inc Modificacion de toxinas de clostridium utilizadas como proteinas de transporte.
GB9508204D0 (en) 1995-04-21 1995-06-07 Speywood Lab Ltd A novel agent able to modify peripheral afferent function
GB9617671D0 (en) 1996-08-23 1996-10-02 Microbiological Res Authority Recombinant toxin fragments
GB9721189D0 (en) 1997-10-08 1997-12-03 Speywood Lab The Limited Analgesic conjugates
DE69938293T2 (de) 1998-03-27 2009-03-12 Bruce J. Beverly Hills Bryan Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
US6890745B1 (en) * 2000-07-19 2005-05-10 Chemicon International, Inc. Protease specific cleavable luciferases and methods of use thereof
EP2308978B8 (en) * 2003-10-10 2015-04-08 Promega Corporation Luciferase biosensor
US8753831B2 (en) 2007-06-05 2014-06-17 City Of Hope Methods for detection of botulinum neurotoxin
JP6038649B2 (ja) 2009-05-01 2016-12-07 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 増大した光出力を有する合成オプロフォルスルシフェラーゼ
US20140287433A1 (en) * 2011-07-19 2014-09-25 ETH Zürich Means and methods for determining clostridial neurotoxins
JP2015509372A (ja) 2012-03-07 2015-03-30 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 修飾ルシフェラーゼに基づいて神経毒活性を測定するための手段および方法
JP6300807B2 (ja) * 2012-10-16 2018-03-28 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 神経毒素ポリペプチドの生物学的活性の決定のための細胞試験系
US20160289731A1 (en) * 2012-11-21 2016-10-06 Merz Pharma Gmbh & Co, Kgaa Means and methods for determination of botulinum neurotoxin biological activity
SG10201601929YA (en) 2013-03-15 2016-04-28 Promega Corp Activation Of Bioluminescence By Structural Complementation
JP6608357B2 (ja) * 2013-06-28 2019-11-20 メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー 細胞において神経毒ポリペプチドの生物活性を決定する手段及び方法
EP3981783A1 (en) * 2015-03-26 2022-04-13 President And Fellows Of Harvard College Engineered botulinum neurotoxin
SG11201903523YA (en) 2016-10-20 2019-05-30 Harvard College In vitro and cell based assays for measuring the activity of botulinum neurotoxins
AU2019398214C1 (en) * 2018-12-11 2024-03-28 Q32 Bio Inc. Fusion protein constructs for complement associated disease

Also Published As

Publication number Publication date
CA3040507A1 (en) 2018-04-26
FI3529616T3 (fi) 2023-12-04
DK3529616T3 (da) 2023-12-11
US20190276873A1 (en) 2019-09-12
EP3529616A2 (en) 2019-08-28
ES2963830T3 (es) 2024-04-02
KR102556363B1 (ko) 2023-07-18
SA519401607B1 (ar) 2022-08-04
BR112019007831A2 (pt) 2019-10-01
PL3529616T3 (pl) 2024-03-18
AU2017345560A1 (en) 2019-05-02
EP3529616B1 (en) 2023-09-06
WO2018075783A3 (en) 2018-06-21
WO2018075783A2 (en) 2018-04-26
SG11201903523YA (en) 2019-05-30
HUE064332T2 (hu) 2024-03-28
JP2023011700A (ja) 2023-01-24
KR20190068582A (ko) 2019-06-18
CN110088624A (zh) 2019-08-02
CN110088624B (zh) 2024-01-16
PT3529616T (pt) 2023-12-06
EA039761B1 (ru) 2022-03-10
JP2019532651A (ja) 2019-11-14
US11788069B2 (en) 2023-10-17
MX2019004431A (es) 2019-08-14
US20220356508A1 (en) 2022-11-10
US11306347B2 (en) 2022-04-19
MX2023004733A (es) 2023-05-10
JP7227901B2 (ja) 2023-02-22

Similar Documents

Publication Publication Date Title
EA201990929A1 (ru) In vitro и клеточные анализы измерения активности ботулинических нейротоксинов
MX2015016767A (es) Medios y metodos para la determinacion de la actividad biologica de polipeptidos de neurotoxina en celulas.
EA201590794A1 (ru) Рекомбинантные нейротоксины clostridium botulinum
PH12015502849B1 (en) Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers
EA201291024A1 (ru) Композиции эндорибонуклеаз и способы их использования
MX363017B (es) Métodos y productos para la expresión de proteínas en células.
EA201171148A1 (ru) Антитело-антагонист, специфичное для гетеродимера альфа-4-бета-7
BR112015010550A8 (pt) Usos de lys-c, métodos para fabricação de um polipeptídeo proteoliticamente processado, para fabricação de um polipeptídeo proteoliticamente ativo, para avaliação para um inibidor do polipeptídeo proteoliticamente ativo, e para geração de fragmentos de polipeptídeo, composições, polipeptídeo proteoliticamente ativo, uso do mesmo, molécula de ácido nucléico, vetor, célula e uso de um polipeptídeo processado
ATE554389T1 (de) Apex als marker für lungenkrebs
BR112017003406A2 (pt) genoma de chromobacterium subtsugae
MX2015006301A (es) Medios y metodos para la determinacion de la actividad biologica de la neurotoxina botulinica.
UY31875A (es) Novedosos genes involucrados en la biosíntesis
Schultz et al. Luciferase of the Japanese syllid polychaete Odontosyllis umdecimdonta
BR112014024282A2 (pt) anticorpos ligantes ao receptor b1 da bradicinina
EA202190469A1 (ru) Способы оценки интегрированных нуклеиновых кислот
BR112017012484A2 (pt) vírus isolado, cultura celular, gene que codifica uma proteína, proteína, fragmento de dna, vírus de vetor recombinante vivo, pseudo-partícula, vacina, anticorpo ou antissoro, método para a preparação de uma vacina, e, kit de teste diagnóstico.
WO2011127001A3 (en) Quantum dot-based optical sensors for rapid detection and quantitative analysis of biomolecules and biological materials
EA201691011A1 (ru) Последовательность модифицированного эндолизина el188
SG10201807867XA (en) Simultaneous detection of target protein and target nucleic acids in a single cell
WO2009090269A3 (en) Markers and diagnostic methods for metastasis
EA202091713A1 (ru) Биологический синтез аминокислотных цепей для получения пептидов и белков
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
EA202190892A1 (ru) Клеточные анализы клостридиальных нейротоксинов
MX2015013735A (es) Ensayo biologico de peptidoglicanos.
AR102966A1 (es) ANTICUERPOS MONOCLONALES ESPECÍFICOS PARA EL ANTÍGENO M DEL VIRUS METAPNEUMOVIRUS HUMANO (hMPV), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, ÚTILES PARA LA DETECCIÓN Y EL DIAGNÓSTICO DE LA INFECCIÓN CAUSADA POR hMPV